Dipal Doshi, President and CEO: Entrada Therapeutics TRDA Sell · Filed 23/01/10

Trade details

Type: Insider sale
Amount: $36,198.2
Shares · price: 2,410 sh · $15.02 a share
Held after: 165,835 sh
Stock: Entrada Therapeutics TRDA
Person: Dipal DoshiPresident and CEO
Trade date: 23/01/09
Filed: 23/01/10
Days to filing: 1 days

Sold 1.4% of holdings

Share of holding sold: 1.4%

Entrada Therapeutics trades, last 26 weeks

What else happened in Entrada Therapeutics around then

Filed or reported within 30 days of the trade day · 22/12/10~23/02/08

Dipal Doshi's recent trades

Dipal DoshiCEO
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$28.5K
1,600 sh
$28.5K
Filed 24/07/16
Traded 24/07/15
Dipal DoshiCEO
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$5,400
300 sh
$5,400
Filed 24/07/16
Traded 24/07/12
Dipal DoshiCEO
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$16.2K
1,000 sh
$16.2K
Filed 24/06/14
Traded 24/06/13
Dipal DoshiCEO
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$27K
1,800 sh
$27K
Filed 24/05/20
Traded 24/05/16
Dipal DoshiCEO
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$18.1K
1,200 sh
$18.1K
Filed 24/05/20
Traded 24/05/17

Dipal Doshi, CEO — sold $36.2K of Entrada Therapeutics TRDA · 1.4% of holdings | Whalegun